Resources
Access Europe When: November 14-16 Where: Barcelona, Spain Booth # 1 OM1 will be at the 2024 Access Europe conference! Our clinical expertise and integrated evidence approach bring together real-world data, AI, and automated, regulatory-enabled platforms to help researchers fill in gaps along the patient journey from bench to bedside. Panel Presentation Title: Plenary Session[…]
CNS Summit When: November 10-13 Where: Boston, MA Booth # 611 OM1 will be at the 2024 CNS Summit conference! Our clinical expertise and integrated evidence approach bring together real-world data, AI, and automated, regulatory-enabled platforms to help researchers fill in gaps along the patient journey from bench to bedside. Spotlight Panel Title: From Rare[…]
Authority Magazine October 6, 2024 Read the full article >> Invest in training and upskilling — Ensuring teams are equipped with the necessary skillset to work alongside AI is critical for success and responsible use of the technology. This includes comprehensive training on the foundation of AI, implementing AI, and special use cases of AI in[…]
Market Access Today October 5, 2024 Read the full article >> Key Questions Answered What are the primary areas of specialization for an insights-driven technology and data company? How does such a company (an insights-driven technology and data company) utilize AI in its operations? In what ways does this impact patient outcomes and research advancement?[…]
Healio October 2, 2024 Read the full article >> The future of Alzheimer’s disease detection and treatment may lie in AI-based datasets encompassing an abundance of real-world evidence from a large number of patients, an expert said. Healio spoke to Carl D. Marci, MD, chief clinical officer at Boston-based OM1, to gain his insights into how his[…]
